COVID-19-associated mucormycosis and treatments
Vetriselvan Subramaniyan1, Shivkanya Fuloria2, Hari Kumar Darnal3, Dhanalekshmi Unnikrishnan Meenakshi4, Mahendran Sekar5, Rusli Bin Nordin1, Srikumar Chakravarthi1, Kathiresan V Sathasivam6, Shah Alam Khan4, Yuan Seng Wu7, Usha Kumari8, Kalvatala Sudhakar9, Rishabha Malviya10, Vipin Kumar Sharma11, Neeraj Kumar Fuloria2
1 Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jalan SP 2, Bandar Saujana Putra, 42610 Jenjarom Selangor, Malaysia 2 Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah, Malaysia 3 Jeffrey Cheah School of Medicine & Health Sciences, Monash University, Selangor 47500, Malaysia 4 College of Pharmacy, National University of Science and Technology, 130 Muscat, Sultanate of Oman 5 Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh 30450, Malaysia 6 Faculty of Applied Science & Centre of Excellence for Biomaterials Engineering, AIMST University, Kedah, Bedong 08100, Malaysia 7 Centre for Virus and Vaccine Research & Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Selangor 47500, Malaysia 8 Faculty of Medicine, AIMST University, Kedah 08100, Malaysia 9 School of Pharmaceutical Sciences (LIT-Pharmacy), Lovely Professional University, Jalandhar 144411, India 10 Department of Pharmacy, SMAS, Galgotias University, Greater Noida 203201, India 11 Department of Pharmaceutical Sciences, Gurukul Kangri, Haridwar, Uttarakhand 249404, India
Correspondence Address:
Neeraj Kumar Fuloria Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah Malaysia Shivkanya Fuloria Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah Malaysia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/1995-7645.326253
|